In fact, in the first year after initiation, total non-GLP-1 spending increases by $585
A comprehensive database search was conducted in PubMed, MEDLINE, Scopus, Embase, and Google Scholar covering the period from inception (1996, 1966, 2004, 1947 and 2004, respectively) to September 2025
10.3390/nu14193937 [DOI] [PMC free article] [PubMed] [Google Scholar] 22
3,5 In early T2DM managed with lifestyle alone, orforglipron lowered glycated hemoglobin A1c (HbA1c) by -1.24 to -1.48 percentage points over 40 weeks as compared to -0.41 with placebo, with no severe hypoglycemia reported and weight reduction ranging from 4.5% to 7.6%, 3 which led to mean HbA1c levels of 6.5-6.7%
The primary endpoint is change in DAS28-CRP at week 12, a validated measure of RA disease activity